You are here

  • Home
  • Archive
  • Volume 21, Issue 4
  • Large ovarian cancer screening trial shows modest mortality reduction, but does not justify population-based ovarian cancer screening

Article info

Article menu
Download PDFPDF
Diagnosis
Randomised controlled trial
Large ovarian cancer screening trial shows modest mortality reduction, but does not justify population-based ovarian cancer screening

Authors

  1. Correspondence to : Dr Nicolas Wentzensen, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Room 7-E114; Bethesda, MD 20892, USA; wentzenn{at}mail.nih.gov
View Full Text

Citation

Wentzensen N
Large ovarian cancer screening trial shows modest mortality reduction, but does not justify population-based ovarian cancer screening
BMJ Evidence-Based Medicine 2016;21:159.

Publication history

  • First published July 22, 2016.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/